首页> 外文期刊>Nephron >Influence of Obesity on Progressionof Non-Diabetic Chronic Kidney Disease:A Retrospective Cohort Study
【24h】

Influence of Obesity on Progressionof Non-Diabetic Chronic Kidney Disease:A Retrospective Cohort Study

机译:肥胖对非糖尿病慢性肾脏病进展的影响:一项回顾性队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: There is increasing awareness of the impact of obesity on chronic diseases including chronic kidney disease (CKD). Until recently, a limited number of epidemiologic studies have examined the association between obesity and CKD. We conducted a retrospective cohort study to evaluate whether obesity impacts on the rate of non-diabetic CKD progression. Methods:The medical records of 125 non-diabetic CKD patients in the Sheffield Kidney Institute, Sheffield, UK, who have been followed-up for around 10 years, were reviewed. Various socio-demographic, clinical and biochemical parameters were retrospectively collected from the patients' database. Participants were categorized into normal weight, overweight and obese groups. Multivariate regression analysis was used for modelling with estimated glomerular filtration rate (eGFR) reduction per year as the dependent variable to evaluate the impact of obesity (BMI) on CKD progression. Results: Patients studied were mostly CKD stage 3 with a mean GFR of 36.2 ml/min/1.73 m2 for the control group and 44.3 ml/min/1.73 m2 for those who wereE
机译:背景:肥胖对包括慢性肾脏病(CKD)在内的慢性疾病影响的认识不断提高。直到最近,有限的流行病学研究才研究了肥胖与CKD之间的关系。我们进行了一项回顾性队列研究,以评估肥胖是否对非糖尿病性CKD病情发展的速度产生影响。方法:对英国谢菲尔德谢菲尔德肾脏研究所的125名非糖尿病CKD患者的病历进行了大约10年的随访。回顾性地从患者数据库中收集了各种社会人口统计学,临床和生化参数。参与者分为正常体重,超重和肥胖组。使用多元回归分析进行建模,以每年估计的肾小球滤过率减少(eGFR)作为因变量来评估肥胖(BMI)对CKD进展的影响。结果:研究的患者大部分为CKD 3期患者,对照组的平均GFR为36.2 ml / min / 1.73 m2,E组为44.3 ml / min / 1.73 m2

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号